HCPCS Level II
J9186
Injection, etoposide (avyxa), 1 mg
Codes near J9186
These sit next to J9186 in the CMS Level II file. All J codes
- J9179Injection, eribulin mesylate, 0.1 mg
- J9181Injection, etoposide, 10 mg
- J9183Gemcitabine intravesical system, 225 mg
- J9184Injection, gemcitabine hydrochloride (avyxa), 200 mg
- J9185Injection, fludarabine phosphate, 50 mg
- J9187Injection, etoposide, 1 mg
- J9190Injection, fluorouracil, 500 mg
- J9191Injection, fluorouracil (avyxa), 10 mg
- J9192Injection, fluorouracil, 10 mg
- J9196Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 83831-0144-05 | Avopef | Avyxa Pharma, LLC | 100 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.